Underlying mechanisms of cAMP- and glucocorticoid-mediated inhibition of FasL expression in activation-induced cell death

Molecular Immunology
Ana C LibermanEduardo Arzt

Abstract

Glucocorticoids (GCs) and cAMP-dependent signaling pathways exert diverse and relevant immune regulatory functions, including a tight control of T cell death and homeostasis. Both of these signaling molecules inhibit TCR-induced cell death and FasL expression, but the underlying mechanisms are still poorly understood. Therefore, to address this question, we performed a comprehensive screening of signaling pathways downstream of the TCR, in order to define which of them are targets of cAMP- and GC-mediated inhibition. We found that cAMP inhibited NF-κB and ERK pathways through a PKA-dependent mechanism, while Dexamethasone blocked TCR-induced NF-κB signaling. Although GCs and cAMP inhibited the induction of endogenous FasL mRNA expression triggered by TCR activation, they potentiated TCR-mediated induction of FasL promoter activity in transient transfection assays. However, when the same FasL promoter was stably transfected, the facilitatory effect of GCs and cAMP became inhibitory, thus resembling the effects on endogenous FasL mRNA expression. Hence, the endogenous chromatinization status known to occur in integrated or genomic vs. episomic DNA might be critical for proper regulation of FasL expression by cAMP and GCs. Our res...Continue Reading

References

Mar 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·K BrownU Siebenlist
Oct 7, 1997·Molecular and Cellular Biology·A PhilipsJ Drouin
Nov 5, 1997·The Journal of Biological Chemistry·C L Smith, G L Hager
Mar 21, 1998·The Journal of Biological Chemistry·C J Holtz-HeppelmannC V Paya
Jun 25, 1998·Molecular and Cellular Biology·P R Mittelstadt, J D Ashwell
Apr 10, 1999·The Journal of Biological Chemistry·M R van den BrinkS J Burakoff
Oct 3, 1999·European Journal of Immunology·S C HsuM Z Lai
Jan 7, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·B BielekovaR Martin
Jun 3, 2000·Annual Review of Immunology·J D AshwellM S Vacchio
Jan 6, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M SchmidtT Kucharzik
Nov 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Michael J PinkoskiDouglas R Green
Feb 13, 2003·Molecular and Cellular Endocrinology·Hui-Bao GaoMatthew P Hardy
May 20, 2003·Immunological Reviews·Douglas R GreenMichael Pinkoski
Sep 24, 2004·Current Pharmaceutical Design·A Dostert, T Heinzel
Feb 15, 2005·The Journal of Biological Chemistry·Tamara TanosOmar A Coso
Nov 30, 2005·Cellular and Molecular Life Sciences : CMLS·M J HeroldH M Reichardt
Mar 23, 2006·Annual Review of Immunology·Nicolas BidèreMichael J Lenardo
May 20, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Adriana del ReyHugo O Besedovsky
Jun 14, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Natalia NovacThorsten Heinzel
May 8, 2007·Cell·Marcus E PeterDavid H Lynch
Jun 26, 2007·Nature Reviews. Immunology·Peter H KrammerInna N Lavrik
Dec 20, 2008·Molecular Endocrinology·Karolien De Bosscher, Guy Haegeman
Feb 26, 2009·Immunity·Andreas StrasserShigekazu Nagata
Jun 23, 2009·Nature Reviews. Immunology·Philippe Bouillet, Lorraine A O'Reilly
Feb 18, 2010·Genes & Development·Jerome S MenetMichael Rosbash

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Alternative splicing

Alternative splicing a regulated gene expression process that allows a single genetic sequence to code for multiple proteins. Here is that latest research.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.